ACI Biosciences
- Company typePrivate
- Founded2000
- HeadquartersChevy Chase, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
ACI Biosciences firmographics
Firmographics- Name
- ACI Biosciences
- Legal name
- ACI Biosciences
- Website
- https://acibiosciences.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
ACI Biosciences industry classification
Industry- Product category
- Veterinary Contract Research and Product Development Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Companion Animal Therapeutics (Rx) (HLAMAEAA), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)
Keywords
Where ACI Biosciences is headquartered
LocationHeadquarters
- HQ city
- Chevy Chase
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
ACI Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Contract Research Services: ACI Biosciences provides product development services for pharmaceuticals and biologicals to animal health industry sponsors. Services include study design, regulatory guidance, clinical trial conduct, pharmacokinetics/pharmacodynamics analyses, and full development programs.
- CMC Solutions: Chemistry, Manufacturing and Controls professional services including project management, API process chemistry, formulation development, manufacturing process development, analytical methods, quality assurance/control, regulatory guidance, and process validation.
- Clinical Trial Conduct: Sponsored clinical trials funded by animal health companies seeking regulatory approval for new veterinary products. ACI conducts multicenter, randomized, placebo-controlled clinical studies.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
ACI Biosciences product offering
Product offeringCore offering
ACI Biosciences provides contract research and product development services to animal health pharmaceutical and biotech sponsors. Offerings encompass GCP-compliant clinical trial design and conduct, regulatory guidance and submissions, CMC (chemistry, manufacturing and controls) solutions, pharmacokinetics/pharmacodynamics analyses, and translational medicine leveraging comparative oncology. The company delivers work through an established network of board-certified veterinary specialists and general practitioners in the US, Canada, and Brasil.
Product overview
ACI Biosciences is a comprehensive product development services company for animal health, offering an integrated platform of services including Research & Development (study conduct, regulatory submissions, pharmacokinetics/pharmacodynamics), CMC Solutions (chemistry, manufacturing, controls, analytical development), and Translational Medicine. The company operates through an established network of clinical investigators and subject matter experts, providing services from pre-clinical through post-market stages for pharmaceuticals, biologicals, and vaccines. ACI Brasil extends these capabilities to Brazil. The core offering is service-based product development rather than a singular software product.
Differentiator
Problem solved
Functional benefit
Products and services
- Research & Development Services Comprehensive product development services for pharmaceuticals, biologicals, and vaccines for animal health, including GCP-compliant study conduct, pharmacokinetics/pharmacodynamics analyses, regulatory guidance and submissions, and new product development planning for animal health industry sponsors.
- CMC Solutions Chemistry, Manufacturing and Controls professional services covering API process chemistry, formulation and manufacturing process development, analytical methods development and validation, quality assurance and quality control, regulatory guidance, and process validation from concept through commercial launch for animal health sponsors.
- Translational Medicine Translational clinical research services leveraging comparative oncology expertise to advance product candidates that may benefit both people and their pets, bridging safety and effectiveness across species for animal health sponsors and the translational medicine research community.
Quantifiable outcome
- 23+ years of veterinary product development experience since October 2000
- +3 more outcomes
Companies that use ACI Biosciences
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles1 record
ACI Biosciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
ACI Biosciences partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Board-Certified Veterinary Specialists and General PractitionerscoreACI Biosciences has established a well-trained network of board-certified veterinary specialists and general practitioners in private practice and academic medicine across the United States, Canada, and Brasil. These investigators provide unparalleled access to expertise for clinical study conduct and product development support. The network includes specialists in oncology, internal medicine, surgery, and other veterinary disciplines.
- CMO/CDMO PartnerscoreACI Biosciences manages relationships with Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) for API manufacturing, formulation development, and GMP production. The CMC team provides comprehensive management of these relationships ensuring seamless communication, supplier oversight, and alignment of development plans.
Scale indicators5 records
Recent moves9 records
Expansion highlights6 records
ACI Biosciences competitors and assessment
Company assessmentBroad incumbents
- Parexel International: Global CRO with clinical development and regulatory services. Selected by animal-health sponsors for larger pivotal trials where global infrastructure matters.
- Labcorp Drug Development (Fortrea): Large clinical CRO spun out from Labcorp. Competes for veterinary clinical trial work where global site network and central lab scale are required.
- PPD (Thermo Fisher Scientific): Large CRO owned by Thermo Fisher covering full clinical development lifecycle. Competes for animal-health sponsors' pivotal trials alongside ICON, Parexel, and Labcorp.
- WuXi AppTec: Large global CRO/CDMO covering discovery through clinical development. Competes for veterinary pharma sponsors seeking broad development capabilities, though its core focus is human health.
- ICON plc: Global clinical CRO with extensive Phase I-IV trial capabilities. Competes for veterinary clinical trial engagements and offers comparable sponsor-facing professional services.
- Charles River Laboratories: Global CRO/CDMO offering preclinical, clinical, and manufacturing services across human and animal health. Competes for end-to-end veterinary product development work via its Research Models & Services and CDMO segments.
Emerging players
- Inotiv: Preclinical and clinical research organization offering animal model and safety assessment services. Overlaps with ACI on preclinical and translational work for animal health products.
Others
- Zoetis: Largest animal health pharma company and likely ACI sponsor or potential in-houser of CRO capabilities. Not a direct competitor but a key counterparty that shapes demand for veterinary CRO services.
Direct peers
- ClinVet International: South Africa-based veterinary CRO offering preclinical and clinical development services for animal health products. Direct competitor in the veterinary CRO niche with comparable target market and service mix.
- Argenta (Galderma): Contract research and manufacturing organization focused on animal health and skin health product development. Directly competes for veterinary pharma and biologics development mandates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ACI Biosciences social profiles
Digital presenceACI Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
ACI Biosciences leadership team
Management profileNumber of profiles
Profiles15 records
ACI Biosciences subsidiaries and ownership
Company hierarchySubsidiaries1 record
ACI Biosciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ACI Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ACI Biosciences
What does ACI Biosciences do?
ACI Biosciences provides contract research and product development services to animal health pharmaceutical and biotech sponsors. Offerings encompass GCP-compliant clinical trial design and conduct, regulatory guidance and submissions, CMC (chemistry, manufacturing and controls) solutions, pharmacokinetics/pharmacodynamics analyses, and translational medicine leveraging comparative oncology. The company delivers work through an established network of board-certified veterinary specialists and general practitioners in the US, Canada, and Brasil.
Is ACI Biosciences a public or private company?
ACI Biosciences is a private company. It is classified as family owned and is currently operating.
When was ACI Biosciences founded?
ACI Biosciences was founded in 2000. It employs 11 to 50 people.
Where is ACI Biosciences based?
ACI Biosciences is headquartered in Chevy Chase, United States, in the North America region.
How does ACI Biosciences make money?
Three revenue lines are on record. Contract Research Services are the primary driver. The others are CMC Solutions and clinical Trial Conduct.
Who are ACI Biosciences's main competitors?
Broad incumbents on record are Parexel International, Labcorp Drug Development (Fortrea), PPD (Thermo Fisher Scientific), WuXi AppTec, ICON plc and Charles River Laboratories. Inotiv is listed as an emerging player. Zoetis is listed as an others. Direct peers are ClinVet International and Argenta (Galderma).
Does ACI Biosciences have an API?
No public API is recorded for ACI Biosciences.
What industry is ACI Biosciences in?
ACI Biosciences's product category is Veterinary Contract Research and Product Development Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAMAEAA, Companion Animal Therapeutics (Rx). Its NAICS code is 5417 and its SIC code is 8731.